Analysis of tumor biopsies pre- and post-CRS-207 treatment revealed potential T cell reinvigoration and proliferation, increased infiltration of dendritic and natural killer cells, increased CD8/Treg ratio, and a shift from immunosuppressive M2-like to proinflammatory M1-like macrophages after CRS-207 administration. This evidence concerns the gene CD8A and neoplasm.